High expression of a vascular stricture‐related marker is predictive of an early response to tolvaptan, and a low fractional excretion of sodium is predictive of a poor long‐term survival after tolvaptan administration for liver cirrhosis-Reference-Cited by-同舟云学术

High expression of a vascular stricture‐related marker is predictive of an early response to tolvaptan, and a low fractional excretion of sodium is predictive of a poor long‐term survival after tolvaptan administration for liver cirrhosis

Published:2020-12 Issue:12 Volume:50 Page:1347-1354
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Adachi Takuya¹,Takaki Akinobu¹,Sato Shuichi²³,Tobita Hiroshi²^ORCID,Kobashi Haruhiko⁴,Kinomura Masaru¹³,Nakatsuka Atsuko³,Oyama Atsushi¹,Wada Nozomu¹^ORCID,Sakata Masahiro¹,Takeuchi Yasuto¹,Yasunaka Tetsuya¹,Onishi Hideki¹,Shiraha Hidenori¹,Okada Hiroyuki¹

Affiliation:

1. Departments of Gastroenterology and Hepatology, and Medical Science Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kita‐ku Okayama Japan

2. Department of Gastroenterology and Hepatology² Shimane University Faculty of Medicine Izumo Shimane Japan

3. Department of Internal Medicine Izumo City General Medical Center Nadabun‐cho Izumo Shimane Japan

4. Department of Hepatology Japanese Red Cross Okayama Hospital Kita‐Ku Okayama Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13573

Reference38 articles.

1. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis

2. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1

3. Terlipressin and albumin combination treatment in patients with hepatorenal syndrome type 2

4. In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V₁ and V₂

5. Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan;International Journal of Molecular Sciences;2021-05-25

2. Cardiovascular Neuroendocrinology: Emerging Role for Neurohypophyseal Hormones in Pathophysiology;Endocrinology;2021-04-23